A small-molecule NNMT inhibitor (not a peptide), 99% purity and HPLC-verified
doi:10.1016/j.drup.2012.07.002
Used together, they provide stronger and longer growth hormone support than either one alone
Age, sex, nutritional status, adiposity, dietary preferences, habits such as smoking, use of concurrent medications, physiologic states such as pregnancy, pathologic states such as liver disease, and others can affect one or more of the 3 processes listed above, thereby influencing the half-life of psychotropic and other drugs
By recruiting additional cells from surrounding areas, BPC-157 overcomes one of the main limitations in connective tissue healing
While both peptides share some similarities in their origin and potential effects, their combined use has not been extensively studied in clinical settings